LJUBLJANA, July 28 (Reuters) - Slovenian generic drugs
producer Krka's KRKG.LJ group net profit fell 38 percent to
70.1 million euros ($77.73 million) in the first half of 2016,
the company said on Thursday.
It said the profit fall was due to lower prices of
pharmaceuticals and the devaluation of some currencies. It also
confirmed its earlier report that group sales rose by 1 percent
to 603.8 million euros in the same period.
($1 = 0.9019 euros)
(Reporting by Marja Novak; editing by Susan Thomas)
((Marja.Novak@thomsonreuters.com; +386-1-5058805; Reuters
Messaging: marja.novak.thomsonreuters.com@reuters.net))
Keywords: SLOVENIA KRKA/